Claritev Corporation/$CTEV
1D1W1MYTD1Y5YMAX
Capital at risk
About Claritev Corporation
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
- Ticker
- $CTEV
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 3,000
- Headquarters
- McLean, United States
- Website
- www.claritev.com
CTEV Metrics
BasicAdvanced
$618M
-
-$16.99
0.79
-
Price and volume
Market cap
$618M
Beta
0.79
52-week high
$73.68
52-week low
$11.50
Average daily volume
125K
Financial strength
Current ratio
0.995
Quick ratio
0.687
Long term debt to equity
-16.233
Total debt to equity
-16.307
Interest coverage (TTM)
0.23%
Profitability
EBITDA (TTM)
555.113
Gross margin (TTM)
72.97%
Net profit margin (TTM)
-28.46%
Operating margin (TTM)
11.02%
Effective tax rate (TTM)
23.41%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
1.39%
Return on equity (TTM)
172.76%
Valuation
Price to revenue (TTM)
0.611
Price to book
-2.1
Price to tangible book (TTM)
-0.14
Price to free cash flow (TTM)
-33.886
Free cash flow yield (TTM)
-2.95%
Free cash flow per share (TTM)
-1.075
Growth
Revenue change (TTM)
6.32%
Earnings per share change (TTM)
-58.37%
3-year revenue growth (CAGR)
0.98%
3-year earnings per share growth (CAGR)
-26.01%
Bulls say / Bears say
Claritev delivered Q2 2026 revenues of $257.5 million, up 6.6% year-over-year, marking the highest quarterly revenue in 15 quarters and its fifth consecutive quarter of top-line growth (Reuters).
Management raised full-year 2026 guidance to $1.00 billion–$1.02 billion in revenues and $610 million–$620 million in adjusted EBITDA, reflecting confidence in sustained momentum (Reuters).
Claritev was named a Leader in Everest Group’s 2026 Pre-payment Integrity Solutions PEAK Matrix® Assessment, validating its market-leading payment integrity and AI-enabled capabilities (Yahoo Finance).
Claritev’s adjusted EBITDA margin contracted to 60.5% in Q2 2026 from 63.8% in Q2 2025, signaling profitability pressure as the company invests in growth initiatives (Reuters).
The company carries approximately $4.7 billion of debt with a net leverage ratio of 7.7× trailing adjusted EBITDA, constraining financial flexibility and increasing refinancing risk (Reuters).
The U.S. Department of Justice has expanded its antitrust probe into Claritev, issuing civil investigative demands over alleged coordination on out-of-network reimbursement rates, heightening regulatory and legal uncertainties (Bloomberg Law).
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2026.
Upcoming events
No upcoming events
CTEV News
AllArticlesVideos
Funds containing CTEV
Fund name | Fund size | $CTEV weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.